These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6486990)

  • 1. Disseminated disease due to Mycobacterium chelonei treated with amikacin and cefoxitin. Absence of killing with either agent and possible role of granulocytes in clinical response.
    Carpenter JL; Troxell M; Wallace RJ
    Arch Intern Med; 1984 Oct; 144(10):2063-5. PubMed ID: 6486990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.
    Wallace RJ; Swenson JM; Silcox VA; Bullen MG
    J Infect Dis; 1985 Sep; 152(3):500-14. PubMed ID: 3875667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei.
    Dalovisio JR; Pankey GA; Wallace RJ; Jones DB
    Rev Infect Dis; 1981; 3(5):1068-74. PubMed ID: 7339806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disseminated Mycobacterium chelonei infection: response to sulfonamides.
    Tice AD; Solomon RJ
    Am Rev Respir Dis; 1979 Jul; 120(1):197-201. PubMed ID: 464378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational resistance as the mechanism of acquired drug resistance to aminoglycosides and antibacterial agents in Mycobacterium fortuitum and Mycobacterium chelonei. Evidence is based on plasmid analysis, mutational frequencies, and aminoglycoside-modifying enzyme assays.
    Wallace RJ; Hull SI; Bobey DG; Price KE; Swenson JM; Steele LC; Christensen L
    Am Rev Respir Dis; 1985 Aug; 132(2):409-16. PubMed ID: 4026065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disseminated Mycobacterium chelonei infection following cadaveric renal transplantation: favorable response to cefoxitin.
    Mehta R; Oliver LD; Melillo D; Milliorn K; Flye W; Fish J
    Am J Kidney Dis; 1983 Sep; 3(2):124-8. PubMed ID: 6351599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of amikacin, erythromycin and doxycyline against Mycobacterium chelonei and Mycobacterium fortuitum.
    Garcia-Rodriguez JA; Martin-Luengo F
    Tubercle; 1978 Dec; 59(4):277-80. PubMed ID: 726085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disseminated Mycobacterium chelonae ssp. abscessus in an immunocompetent host and with a known portal of entry.
    Nelson BR; Rapini RP; Wallace RJ; Tschen JA
    J Am Acad Dermatol; 1989 May; 20(5 Pt 2):909-12. PubMed ID: 2715444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterium chelonei tenosynovitis.
    Zachary LS; Clark GL; Kleinert JM; O'Donovan C
    Ann Plast Surg; 1988 Apr; 20(4):360-2. PubMed ID: 3364921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of amikacin against Mycobacteria in vitro and in murine tuberculosis.
    Sanders WE; Hartwig C; Schneider N; Cacciatore R; Valdez H
    Tubercle; 1982 Sep; 63(3):201-8. PubMed ID: 6817487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefoxitin therapy for Mycobacterium fortuitum bacteremia with associated granulomatous hepatitis.
    Brannan DP; DuBois RE; Ramirez MJ; Ravry MJ; Harrison EO
    South Med J; 1984 Mar; 77(3):381-4. PubMed ID: 6422563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients.
    Jeon K; Kwon OJ; Lee NY; Kim BJ; Kook YH; Lee SH; Park YK; Kim CK; Koh WJ
    Am J Respir Crit Care Med; 2009 Nov; 180(9):896-902. PubMed ID: 19661243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus Infection.
    Ferro BE; Srivastava S; Deshpande D; Pasipanodya JG; van Soolingen D; Mouton JW; van Ingen J; Gumbo T
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6374-6. PubMed ID: 27458221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing.
    Huang YC; Liu MF; Shen GH; Lin CF; Kao CC; Liu PY; Shi ZY
    J Microbiol Immunol Infect; 2010 Oct; 43(5):401-6. PubMed ID: 21075707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of the regimen containing cefoxitin on highly drug-resistant rapidly growing nontuberculous mycobacterial pulmonary disease].
    Sha W; Liang L; Jiang RH; Fang Y; Yin HY; Xiao HP
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Apr; 34(4):265-8. PubMed ID: 21609609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility of Mycobacterium marinum to dihydromycoplanecin A and ten other antimicrobial agents.
    Arai H; Nakajima H; Kaminaga Y
    J Dermatol; 1990 Jun; 17(6):370-4. PubMed ID: 2384640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus.
    Koh WJ; Jeon K; Lee NY; Kim BJ; Kook YH; Lee SH; Park YK; Kim CK; Shin SJ; Huitt GA; Daley CL; Kwon OJ
    Am J Respir Crit Care Med; 2011 Feb; 183(3):405-10. PubMed ID: 20833823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Otitis media and mastoiditis due to Mycobacterium fortuitum: case report, review of four cases, and a cautionary note.
    Plemmons RM; McAllister CK; Liening DA; Garces MC
    Clin Infect Dis; 1996 Jun; 22(6):1105-6. PubMed ID: 8783722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptiiblity of Mycobacterium fortuitum and Mycobacterium chelonei to amikacin.
    Dalovisio JR; Pankey GA
    J Infect Dis; 1978 Mar; 137(3):318-21. PubMed ID: 632627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
    Gui J; Wang F; Hong CY; Li JL; Liang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):567-71. PubMed ID: 24252731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.